We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$182M
AUM Growth
-$63.1M
Cap. Flow
-$54.9M
Cap. Flow %
-30.16%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
DYN icon
Dyne Therapeutics
DYN
+$54.9M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRDA icon
1
Entrada Therapeutics
TRDA
$273M
$63.1M 34.64%
4,425,784
DYN icon
2
Dyne Therapeutics
DYN
$4.68B
$55.1M 30.26%
1,561,496
-1,889,807
-55% -$54.9M
ITOS
3
DELISTED
iTeos Therapeutics
ITOS
$40.6M 22.32%
2,738,785
HOWL icon
4
Werewolf Therapeutics
HOWL
$45.8M
$10.5M 5.74%
4,284,172
RPTX
5
DELISTED
Repare Therapeutics
RPTX
$7.4M 4.06%
2,242,636
ADAP
6
DELISTED
Adaptimmune Therapeutics
ADAP
$5.42M 2.97%
5,555,461

Similar funds

MPM Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, MPM Asset Management held 6 positions worth $182M, down 26% from $245M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MPM Asset Management withdrew a net $54.9M in Q2 2024, reducing 1 holding. Its largest reduction was Dyne Therapeutics, cutting an estimated $54.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MPM Asset Management's biggest Q2 2024 reduction was Dyne Therapeutics, cutting an estimated $54.9M.
  • MPM Asset Management's ten largest holdings make up 100% of its $182M portfolio in Q2 2024.
  • MPM Asset Management opened 0 new positions and closed 0 in Q2 2024.
  • MPM Asset Management's portfolio value fell 26% quarter-over-quarter to $182M.

Based on MPM Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.